Guidance
Evidence-based recommendations on high-throughput non-invasive prenatal testing (NIPT) for fetal RHD genotype.
This guidance should be read with NICE's technology appraisal guidance on routine antenatal anti-D prophylaxis for women who are rhesus D negative.
Is this guidance up to date?
We reviewed the evidence in April 2021. We found nothing new that affects the recommendations in this guidance.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.